Edit |   |
---|---|
Antigenic Specificity | IGF1 & IGF2, Human (Dusigitumab biosimilar) |
Clone | Dusigitumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IGF1 & IGF2 Recombinant Antibody (Dusigitumab). Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGLF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix. |
Immunogen | n/a |
Other Names | Anti-IGF1 & IGF2 Recombinant Antibody, Research Grade Dusigitumab, Anti-Human IGF1 & IGF2 Recombinant Antibody(Dusigitumab), MEDI-573, Antibody Drug Analogues, Monoclonal Antibody, YR1296, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1204390-13-5 |
Catalog # | YR1296 |
Price | please inquire |
Order / More Info | IGF1 & IGF2, Human (Dusigitumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |